PATENT CLAIM ANALYSIS

Application Number: 16193269
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["544", "277000"]

Abstract:
Embodiments of calcium channel agonists, as well as methods of making and using the calcium channel agonists, are disclosed. The disclosed calcium channel agonists and corresponding salt forms have a structure according to general formula I: wherein each bond depicted as “ ” is a single bond or a double bond as needed to satisfy valence requirements; Z 1 , Z 2 , Z 3 , Z 4 , and Z 5  independently are nitrogen or carbon; R 1  and R 3  are alkyl; R 2  is alkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; and R 4  is alkyl or hydroxyalkyl.

Claim (Index 6):
The method of  claim 2 , wherein the method is for inhibiting or relieving motor neuron disease and the motor neuron disease is spinal muscular atrophy, amyotrophic lateral sclerosis, primary lateral sclerosis, progressive bulbar palsy, pseudobulbar palsy, or a combination thereof.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.88333
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15711715', '14892184', '15842823', '16022578', '15897796']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7986048032399904
- 35 USC 102 Novelty (BERT): 0.5977850115014585
- Combined Prediction Score: 0.7785228240661372
- Mean Citation Score: 404.681562
- Max Citation Score: 685.0573
- Similarity Product: 424.594248480928

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test